Allergan Comments On The United States agency Of Justice Subpoena For The Production Of Documents Relating To Promotional Practices Of BOTOX

March 05th, 2008 | Category: Dermatology

Allergan, Inc. (NYSE: AGN) announced that it received a subpoena from the United States area of Justice, United States Attorney’s Office for the Northern District of Georgia requesting the production of documents regarding promotional practices involving

BOTOX® (botulinum toxin type A) for therapeutic indications. The subpoena broadly requests documents regarding promotional, educational and other activities relating to BOTOX®.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • American Society For Dermatologic Surgery Supports Current Labeling Of Allergan’s Botox(R) Products
  • Men Need More Botox Than Women
  • Allergan Announces Intent To File New Drug Application For Bimatoprost As Novel Treatment To Stimulate Natural Eyelash Growth
  • Female Urology - Urinary Incontinence Leads To Decreased Mental Health And High Psychosocial Stress
  • Telfonix.com Now Offers Medical Document Scanning & Storage

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.